You just read:

TAILORx trial finds 99 percent of women with low Oncotype DX® Recurrence Score® are free of breast cancer recurrence after five years of hormone therapy alone

News provided by

Genomic Health, Inc.; ECOG-ACRIN Cancer Research Group

Sep 28, 2015, 01:15 ET